Shares of Rite Aid RAD are down 4.4 percent amid investor speculation on common trends in its price graph.
Rite Aid has been testing the $7 price level since the drug retailer's positive Q4 earnings release in April, followed by a short-lived rally to all-time highs of $8.61. Following Rite Aid's rally from late April to early June, shares faced a modest sell-off, retracing back to the low $7 range.
It appears that traders have identified the $7 price level as a focus, being right above the mean 50 percent level year to date.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.